SARS‐CoV‐2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022E. Wangeci Kagucia, Ambrose Agweyu, Maurine Ng’oda et al.|Influenza and Other Respiratory Viruses|2023Cited by 24
SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-June 2022EW Kagucia, Ambrose Agweyu, Abdhalah Ziraba et al.|medRxiv|2022Cited by 9
Author response for "SARS‐CoV‐2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022"E. Wangeci Kagucia, Ambrose Agweyu, Abdhalah Ziraba et al.|Unknown|2023Cited by 0